{
    "analytics_identifier":  null,
    "base_path":  "/guidance/guidance-on-converting-parallel-distribution-notices-pdns-to-uk-parallel-import-licences-pils-in-a-no-deal-scenario",
    "content_id":  "2644bb7f-9508-45c8-8ecb-b6626fd25bd2",
    "description":  "The process to convert Parallel Distribution Notices (PDNs) into Parallel Import Licences (PILs) in a no-deal Brexit",
    "details":  {
                    "attachments":  [

                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eIn a no-deal Brexit, the UK will need to put in place arrangements for the continued authorisation of medicinal products.\u003c/p\u003e\n\n\u003cp\u003eThis guidance provides detailed description of the process we have put in place to convert your Parallel Distribution Notices (\u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e) into Parallel Import Licences (\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e) in the event of a no-deal Brexit.\u003c/p\u003e\n\n\u003ch2 id=\"how-to-convert-your-pdn-to-a-pil\"\u003eHow to convert your \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e to a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders are given the opportunity to opt-in to the conversion process for all or some of their \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e by notifying the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e in writing as described below. This process requires minimal information from \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders.\u003c/p\u003e\n\n\u003cp\u003eIf you choose not to opt-in, following the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e your product(s) will no longer be licensed in the UK and you will no longer be able to place them on the market in the UK.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will allocate Product Licence (\u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e) numbers to \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e based on the existing practice for determining how many separate national licences are needed across a product range. All pack sizes will be covered by a single \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will be valid for a single source country and a separate \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e will be issued for each source country you request.\u003c/p\u003e\n\n\u003cp\u003eThere is no fee associated with the conversion from a \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e to a UK \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"detailed-description-of-the-process-for-convertingpdnstopils\"\u003eDetailed description of the process for converting \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e to \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003ch3 id=\"actions-to-take-if-you-are-a-pil-holder\"\u003eActions to take if you are a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e holder\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e are being issued as a replacement for \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e (which will no longer be valid in the UK) and will be issued to the holder of the \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holder will need to have a company number allocated by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e as this forms part of the \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number which will be allocated to each \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eIf you do not already have a \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e-allocated company number please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e as soon as possible for instructions on how to apply for a number.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e holders will need to be established in the UK from exit day until the end of the implementation period. If you are a \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holder not established in the UK, but you have an associated company established in the UK which you would like to be the holder of your \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e, \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplease contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e\u003c/a\u003e as soon as possible to make this arrangement.\u003c/p\u003e\n\n\u003cp\u003eIf you do not have an associated, UK-based company you will need to establish a company in the UK beginning on the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e until the end of the implementation period. Please contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e as soon as this company has been allocated a number by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e and your \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will be transferred to the new company for no fee.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-opt-in\"\u003eHow to opt in\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders have been provided with a list of \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e understood to be valid on 31 December 2018. This list will be updated before the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eCheck this list very carefully and please contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e of any discrepancy.\u003c/p\u003e\n\n\u003cp\u003eSome \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e refer to \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e licence numbers which are not listed in the current product information available on the EMA website. These presentations may no longer be valid and \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will not be issued for them unless you specifically request one.\u003c/p\u003e\n\n\u003cp\u003eThe list includes a column for the source countries you want to use for each product. A separate \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e will be issued for each source country you request. If you do not want your \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e for any product converted to a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e, please enter “none” in this column.\u003c/p\u003e\n\n\u003cp\u003eReturn the completed list as soon as possible to \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eYou must return the list within 3 weeks of the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e if you wish to take part in the conversion process. It will not be possible to convert further \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e after the end of this 3-week period and a fresh application for a parallel import licence would be necessary, with the associated fee payable.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-request-further-information-from-companies-involved-in-repacking\"\u003eHow to request further information from companies involved in repacking\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e require some additional information about the companies involved in the repacking process, including the supplier from whom the product is obtained and the companies involved in importing, repacking, batch release, storing and distributing the product.\u003c/p\u003e\n\n\u003cp\u003eSupplier information should be addressed by completing a “supplier commitment”, signed by a company director. This is a commitment to confirm validity of authorisations and to record details of the source of each batch of product repacked. For details of the wording required, please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e. This commitment must be returned before any \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers can be issued and no later than 4 weeks after the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eCompanies involved in repacking are best managed using a “Company Functions List”. This can be updated at any time by submitting an updated list to \u003ca href=\"mailto:plpi.admin@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi.admin@mhra.gov.uk\u003c/a\u003e. The latest list will be applied when a new \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e is granted.\u003c/p\u003e\n\n\u003cp\u003ePlease contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e for a template and example document. This information must be returned before any \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers can be issued and no later than 4 weeks after the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"issue-of-pl-numbers\"\u003eIssue of \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e numbers\u003c/h3\u003e\n\n\u003cp\u003eAs soon as possible after receipt of the list of \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e you require, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will return an updated list which includes a \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number allocated to each product/source country requested.\u003c/p\u003e\n\n\u003ch3 id=\"after-the-uk-leaves-the-eu\"\u003eAfter the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eImmediately after Brexit you may continue to repack and release those products for which you have requested a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e using labels and leaflets consistent with the latest annex on the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website and carrying the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e licence number.\u003c/p\u003e\n\n\u003cp\u003eProducts for which you have not requested a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e may not be released after the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eOnce you have received your list of \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers you should update the labels and leaflet to use these numbers as soon as practicable.\u003c/p\u003e\n\n\u003cp\u003eYou should continue to monitor the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website and update the labels and leaflet used in your released product to remain consistent with the latest annex on the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website.\u003c/p\u003e\n\n\u003ch3 id=\"receipt-of-pils\"\u003eReceipt of \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eWe expect that it will take some months to issue all of the \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e required. They are likely to be produced on a ‘by product’ rather than a ‘by importer’ basis.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e produced will use a substitute UK reference MA to allow cases to be created in our licence management system before the relevant UK MA for the reference product has been issued. A change of UK reference product variation will be applied to each \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e at no fee at a later date.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e produced as part of this process will use the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e annexes for the label and leaflet documents. No “user test” of the patient leaflet will be required.\u003c/p\u003e\n\n\u003ch3 id=\"pil-maintenance\"\u003e\n\u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e maintenance\u003c/h3\u003e\n\n\u003cp\u003eOnce a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e for a converted product is issued the established Parallel Import variation process applies. Variations should be submitted and approved before an affected product is released, unless the change falls within the Tell-and-Do scheme. Scans of samples should be submitted when required.\u003c/p\u003e\n\n\u003cp\u003eThe first variation affecting labels and/or leaflets must be accompanied by a mock-up of the respective document(s). In the case of labels this must begin with the label summary sheet. Please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e for a template.\u003c/p\u003e\n\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"further-information\"\u003eFurther information\u003c/h2\u003e\n\n\u003cp\u003ePlease contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e if you have any questions about this process.\u003c/p\u003e\n\n\u003cdiv class=\"call-to-action\"\u003e\n\u003ch3 id=\"stay-up-to-date\"\u003eStay up to date\u003c/h3\u003e\n\n\u003cp\u003eThis page tells you what to do if you the UK leaves the EU without a deal. It will be updated if anything changes, including if a deal is agreed.\u003c/p\u003e\n\n\u003cp\u003e\u003ca href=\"https://www.gov.uk/email-signup/?topic=/government/brexit\" class=\"govuk-link\"\u003eSign up to email alerts\u003c/a\u003e to get the latest information\u003c/p\u003e\n\n\u003cp\u003e \u003c/p\u003e\n\u003c/div\u003e\n\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eIf there is a no-deal Brexit, the UK will need to put in place arrangements for the continued authorisation of medicinal products.\u003c/p\u003e\n\n\u003cp\u003eThis guidance provides detailed description of the process we have put in place to convert your Parallel Distribution Notices (\u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e) into Parallel Import Licences (\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e) in the event of a no-deal Brexit.\u003c/p\u003e\n\n\u003ch2 id=\"outline-of-the-process-for-converting-pdns-to-pils\"\u003eOutline of the process for converting \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e to \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders are given the opportunity to opt-in to the conversion process for all or some of their \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e by notifying the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e in writing as described below. This process requires minimal information from \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders.\u003c/p\u003e\n\n\u003cp\u003eIf you choose not to opt-in, following the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e your product(s) will no longer be licensed in the UK and you will no longer be able to place them on the market in the UK.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will allocate Product Licence (\u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e) numbers to \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e based on the existing practice for determining how many separate national licences are needed across a product range. All pack sizes will be covered by a single \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will be valid for a single source country and a separate \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e will be issued for each source country you request.\u003c/p\u003e\n\n\u003cp\u003eThere is no fee associated with the conversion from a \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e to a UK \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"detailed-description-of-the-process-for-convertingpdnstopils-1\"\u003eDetailed description of the process for converting \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e to \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e\n\u003c/h2\u003e\n\n\u003ch3 id=\"actions-to-take-if-you-are-a-pil-holder-1\"\u003eActions to take if you are a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e holder\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e are being issued as a replacement for \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e (which will no longer be valid in the UK) and will be issued to the holder of the \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holder will need to have a company number allocated by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e as this forms part of the \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number which will be allocated to each \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eIf you do not already have a \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e-allocated company number please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e as soon as possible for instructions on how to apply for a number.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e holders will need to be established in the UK from exit day until the end of the implementation period. If you are a \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holder not established in the UK, but you have an associated company established in the UK which you would like to be the holder of your \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e, \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplease contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e\u003c/a\u003e as soon as possible to make this arrangement.\u003c/p\u003e\n\n\u003cp\u003eIf you do not have an associated, UK-based company you will need to establish a company in the UK beginning on the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e until the end of the implementation period. Please contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e as soon as this company has been allocated a number by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e and your \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will be transferred to the new company for no fee.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-opt-in-1\"\u003eHow to opt in\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e holders have been provided with a list of \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e understood to be valid on 31 December 2018. This list will be updated before the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eCheck this list very carefully and please contact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e of any discrepancy.\u003c/p\u003e\n\n\u003cp\u003eSome \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e refer to \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e licence numbers which are not listed in the current product information available on the EMA website. These presentations may no longer be valid and \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e will not be issued for them unless you specifically request one.\u003c/p\u003e\n\n\u003cp\u003eThe list includes a column for the source countries you want to use for each product. A separate \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e will be issued for each source country you request. If you do not want your \u003cabbr title=\"Parallel Distribution Notice\"\u003ePDN\u003c/abbr\u003e for any product converted to a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e, please enter “none” in this column.\u003c/p\u003e\n\n\u003cp\u003eReturn the completed list as soon as possible to \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eYou must return the list within 3 weeks of the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e if you wish to take part in the conversion process. It will not be possible to convert further \u003cabbr title=\"Parallel Distribution Notices\"\u003ePDNs\u003c/abbr\u003e after the end of this 3-week period and a fresh application for a parallel import licence would be necessary, with the associated fee payable.\u003c/p\u003e\n\n\u003ch3 id=\"how-to-request-further-information-from-companies-involved-in-repacking-1\"\u003eHow to request further information from companies involved in repacking\u003c/h3\u003e\n\n\u003cp\u003e\u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e require some additional information about the companies involved in the repacking process, including the supplier from whom the product is obtained and the companies involved in importing, repacking, batch release, storing and distributing the product.\u003c/p\u003e\n\n\u003cp\u003eSupplier information should be addressed by completing a “supplier commitment”, signed by a company director. This is a commitment to confirm validity of authorisations and to record details of the source of each batch of product repacked. For details of the wording required, please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e. This commitment must be returned before any \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers can be issued and no later than 4 weeks after the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eCompanies involved in repacking are best managed using a “Company Functions List”. This can be updated at any time by submitting an updated list to \u003ca href=\"mailto:plpi.admin@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi.admin@mhra.gov.uk\u003c/a\u003e. The latest list will be applied when a new \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e is granted.\u003c/p\u003e\n\n\u003cp\u003ePlease contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e for a template and example document. This information must be returned before any \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers can be issued and no later than 4 weeks after the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003ch3 id=\"issue-of-pl-numbers-1\"\u003eIssue of \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e numbers\u003c/h3\u003e\n\n\u003cp\u003eAs soon as possible after receipt of the list of \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e you require, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will return an updated list which includes a \u003cabbr title=\"Product Licence\"\u003ePL\u003c/abbr\u003e number allocated to each product/source country requested.\u003c/p\u003e\n\n\u003ch3 id=\"after-the-uk-leaves-the-eu-1\"\u003eAfter the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eImmediately after Brexit you may continue to repack and release those products for which you have requested a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e using labels and leaflets consistent with the latest annex on the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website and carrying the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e licence number.\u003c/p\u003e\n\n\u003cp\u003eProducts for which you have not requested a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e may not be released after the day the UK leaves the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003eOnce you have received your list of \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e numbers you should update the labels and leaflet to use these numbers as soon as practicable.\u003c/p\u003e\n\n\u003cp\u003eYou should continue to monitor the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website and update the labels and leaflet used in your released product to remain consistent with the latest annex on the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e website.\u003c/p\u003e\n\n\u003ch3 id=\"receipt-of-pils-1\"\u003eReceipt of \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e\n\u003c/h3\u003e\n\n\u003cp\u003eWe expect that it will take some months to issue all of the \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e required. They are likely to be produced on a ‘by product’ rather than a ‘by importer’ basis.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e produced will use a substitute UK reference MA to allow cases to be created in our licence management system before the relevant UK MA for the reference product has been issued. A change of UK reference product variation will be applied to each \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e at no fee at a later date.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Parallel Import Licences\"\u003ePILs\u003c/abbr\u003e produced as part of this process will use the \u003cabbr title=\"European Medicines Agency/European Commission\"\u003eEMA/EC\u003c/abbr\u003e annexes for the label and leaflet documents. No “user test” of the patient leaflet will be required.\u003c/p\u003e\n\n\u003ch3 id=\"pil-maintenance-1\"\u003e\n\u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e maintenance\u003c/h3\u003e\n\n\u003cp\u003eOnce a \u003cabbr title=\"Parallel Import Licence\"\u003ePIL\u003c/abbr\u003e for a converted product is issued the established Parallel Import variation process applies. Variations should be submitted and approved before an affected product is released, unless the change falls within the Tell-and-Do scheme. Scans of samples should be submitted when required.\u003c/p\u003e\n\n\u003cp\u003eThe first variation affecting labels and/or leaflets must be accompanied by a mock-up of the respective document(s). In the case of labels this must begin with the label summary sheet. Please contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e for a template.\u003c/p\u003e\n\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"further-information-1\"\u003eFurther information\u003c/h2\u003e\n\n\u003cp\u003ePlease contact \u003ca href=\"mailto:plpi@mhra.gov.uk\" class=\"govuk-link\"\u003eplpi@mhra.gov.uk\u003c/a\u003e if you have any questions about this process.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Change of text within Stay up to date box.",
                                               "public_timestamp":  "2019-10-09T12:31:50.000+01:00"
                                           },
                                           {
                                               "note":  "Restructured some information and added a call to action.",
                                               "public_timestamp":  "2019-08-08T15:03:02.000+01:00"
                                           },
                                           {
                                               "note":  "Updated information",
                                               "public_timestamp":  "2019-08-07T12:10:02.000+01:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2019-03-18T13:55:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2019-03-18T13:55:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ],
                                 "topics":  [
                                                "6d1048f5-9d18-4045-8562-9b85c71b1c9e"
                                            ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2019-03-18T13:55:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/guidance-on-converting-parallel-distribution-notices-pdns-to-uk-parallel-import-licences-pils-in-a-no-deal-scenario",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/guidance-on-converting-parallel-distribution-notices-pdns-to-uk-parallel-import-licences-pils-in-a-no-deal-scenario",
                                                     "base_path":  "/guidance/guidance-on-converting-parallel-distribution-notices-pdns-to-uk-parallel-import-licences-pils-in-a-no-deal-scenario",
                                                     "content_id":  "2644bb7f-9508-45c8-8ecb-b6626fd25bd2",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2019-10-09T11:31:50Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Converting Parallel Distribution Notices (PDNs) to UK Parallel Import Licences (PILs) in a no-deal Brexit",
                                                     "web_url":  "https://www.gov.uk/guidance/guidance-on-converting-parallel-distribution-notices-pdns-to-uk-parallel-import-licences-pils-in-a-no-deal-scenario",
                                                     "withdrawn":  true
                                                 }
                                             ],
                  "facet_groups":  [
                                       {
                                           "content_id":  "52435175-82ed-4a04-adef-74c0199d0f46",
                                           "document_type":  "facet_group",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:54Z",
                                           "schema_name":  "facet_group",
                                           "title":  "Find EU Exit guidance business",
                                           "withdrawn":  false
                                       }
                                   ],
                  "facet_values":  [
                                       {
                                           "content_id":  "93f5c156-2449-4e52-9e92-aefc73586ffd",
                                           "document_type":  "facet_value",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:58Z",
                                           "schema_name":  "facet_value",
                                           "title":  "Pharmaceuticals and clinical trials",
                                           "withdrawn":  false
                                       }
                                   ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "content_id":  "f4f28e9d-2050-45fb-ab76-78c0345670da",
                                     "details":  {
                                                     "internal_name":  "Marketing authorisations, variations and licensing guidance [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:21Z",
                                     "schema_name":  "taxon",
                                     "title":  "Marketing authorisations, variations and licensing guidance",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-marketing-authorisations-variations-licensing",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2019-10-09T12:31:50+01:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "24293-1631014184.580-10.13.5.96-539",
    "publishing_scheduled_at":  null,
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  null,
    "schema_name":  "detailed_guide",
    "title":  "Converting Parallel Distribution Notices (PDNs) to UK Parallel Import Licences (PILs) in a no-deal Brexit",
    "updated_at":  "2024-11-14T17:48:10+00:00",
    "withdrawn_notice":  {
                             "explanation":  "\u003cdiv class=\"govspeak\"\u003e\u003cp\u003eThis guidance is no longer valid. For current info please see \u003ca href=\"https://www.gov.uk/guidance/medicines-apply-for-a-parallel-import-licence\" class=\"govuk-link\"\u003eApply for a parallel import licence\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e",
                             "withdrawn_at":  "2020-02-24T10:56:40Z"
                         }
}
